Ali M Sharifi - Department of Pharmacology, Medical School & Department of Tissue Engineering and Regenerative Medicine, School of Advance Sciences in Medical Sciences, Tehran, Iran

Degenerative diseases are substantially growing and serious health threat worldwide. Regenerative pharmacology as a branch of regenerative medicine is a novel therapeutic approach with goal of preventing, repairing and regenerating the progressive cell destruction which were mediated by various etiological factors causing these disorders. This approach works to identify useful molecular targets for regenerative and therapeutic purposes. By restoring the development and function of tissues and organs, regenerative pharmacology has the ability to improve therapies for many human diseases. Stem cell-based regenerative pharmacology supports the use of stem cells for derivation of novel therapeutics. Various regenerative pharmacological approaches would be able to affect all aspect of stem cell and regenerative medicine as well as tissue engineering researches including; mobilization, expansion, differentiation, homing, functional improvement, reprogramming of stem cell, drug delivery, and many others.Ultimately, stem cell-based regenerative pharmacology aims to establish stem and progenitor cells as effective treatments for preventing disease and for facilitating organ replacement or repair. This promising area of basic and clinically oriented research opens up numerous new opportunities for pharmacology.

Regenerative pharmacology, Regenerative medicine